Harpoon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Harpoon Therapeutics

09/08/2023 21:50

* Harpoon Therapeutics Inc  HARP.OQ  reported quarterly
adjusted
earnings of 3 cents​​ per share for the quarter ended in June.
The mean expectation of seven analysts for the quarter was for a
loss of 34 cents per share.
    * Revenue rose 143.5% to $20.22 million from a year ago;
analysts
expected $5.15 million. 
    * Harpoon Therapeutics Inc's reported EPS for the quarter
was 3
cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harpoon Therapeutics Inc shares had risen by 11.3% this
quarter and gained 8.9% so far this year.
    * The company reported quarterly net income of $1.06
million.
    * Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $5.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 08:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.34          0.03           Beat
 Mar. 31 2023      -0.38          -0.31          Beat
 Dec. 31 2022      -0.47          -0.55          Missed
 Sep. 30 2022      -0.56          -0.35          Beat